© 2021 Osprey Medical Inc. All rights reserved.
Osprey Medical, DyeVert, DyeMINISH, and Be Kind to Kidneys are registered Trademarks of Osprey Medical, Inc. in the United States and other countries.
Harness the Power, Protect the Kidneys
The DyeVert™ Power XT is designed to optimize the amount of contrast media administered to the patient by automated contrast injectors during angiographic procedures.
DyeVert™ Power XT is a dye management solution for patients with at-risk kidney factors, including:
Moderate and severe chronic kidney disease
Diabetes
Older age
Heart failure
Dye reduction
DyeVert™ Power XT reduces contrast dye delivery to the patient without compromising image quality.
Proven results
Clinical results show that DyeVert™ Power XT incrementally reduces contrast by an average of 34% when used with an automated power injector.1
Smart Bag
Smart Contrast Collection Bag digitally displays estimated diverted (saved) contrast volume.
1 Amorosa G, Jung C, Abell C. First European experience using a novel contrast reduction system during coronary angiography with automated contrast injection. EuroIntervention June 2020, vol 16, supplement AC: Abstracts Book PCR e-Course 2020, page 387. Poster Abstract No. Euro20A-POS426.
Indications, contraindications, warnings, and instructions for use can be found in the product labeling supplied with each device. Risks may include air emboli and infection.
Australian Sponsor
Osprey Medical, Pty
Level 13, 41 Exhibition Street
Melbourne, Victoria 3000 Australia
Uncompromised Imaging: Seeing is Believing
Injections into coronary arteries may result in excess reflux into the aorta that is not needed for imaging. DyeVert™ Power XT reduces contrast amount without compromising image quality. See for yourself.
Without contrast reduction
With DyeVert™ Power XT contrast reduction
DyeVert™ Power XT Technology Disposables
DyeVert™ Power XT Technology Set-Up
DyeVert™ Power XT Contrast Reduction System is easy to set-up and use with automated power injectors.